


CYP26B1 Antibody (2G7) is a mouse monoclonal IgG2a kappa light chain antibody that detects CYP26B1 protein of human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). Anti-CYP26B1 antibody (2G7) is available as a non-conjugated format. CYP26B1, also known as cytochrome P450 retinoic acid-inactivating 2 (P450RAI2), plays a crucial role in retinoic acid metabolism, a derivative of vitamin A essential for various biological processes, including embryonic development, cell differentiation, and tissue homeostasis. CYP26B1 is primarily localized to endoplasmic reticulum and microsome membranes, with significant expression in brain, particularly in cerebellum and pons, highlighting CYP26B1′s importance in neurological functions. CYP26B1 is responsible for specific inactivation of all-trans-retinoic acid, converting CYP26B1 into several hydroxylated forms, which is vital for maintaining appropriate retinoic acid levels in tissues and preventing potential toxic effects from accumulation. CYP26B1′s ability to regulate retinoic acid levels underscores CYP26B1′s significance in developmental biology and potential implications in various diseases, including cancer and neurodegenerative disorders.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
CYP26B1 Antibody (2G7) | sc-293493 | 100 µg/ml | $322.00 |